Skip to content
Disclosery

Maple-Brown Abbott Ltd: AEE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on AEE, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 1,363,770 AEE shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 1,363,770 shares
    Change vs previous 13F +93,530 shares

    9.34% of the 13F portfolio, value $136,933,494.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 1,270,240 shares
    Change vs previous 13F -361,690 shares

    13.81% of the 13F portfolio, value $113,229,194.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 1,631,930 shares
    Change vs previous 13F -121,340 shares

    14.16% of the 13F portfolio, value $142,728,597.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 1,753,270 shares
    Change vs previous 13F +38,750 shares

    13.15% of the 13F portfolio, value $124,675,030.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 1,714,520 shares
    Change vs previous 13F +139,660 shares

    12.97% of the 13F portfolio, value $126,805,899.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 1,574,860 shares
    Change vs previous 13F +223,790 shares

    11.6% of the 13F portfolio, value $113,925,372.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 1,351,070 shares
    Change vs previous 13F -35,960 shares

    11.6% of the 13F portfolio, value $101,100,569.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-06-30
    13F/A 1,387,030 shares
    Change vs previous 13F not available

    12.58% of the 13F portfolio, value $113,278,741.

    13F-HR/A 0001681596-24-000008 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).